(Accessed 14 June2014)
Antiretroviral Therapy for Refugees and Internally Displaced Persons: A Call for Equity
Joshua B Mendelsohn mail, Paul Spiegel, Marian Schilperoord, Nadine Cornier, David A. Ross
Published: June 10, 2014
:: Available evidence suggests that refugees and internally displaced persons (IDPs) in stable settings can sustain high levels of adherence and viral suppression.
:: Moral, legal, and public health principles and recent evidence strongly suggest that refugees and IDPs should have equitable access to HIV treatment and support.
:: Exclusion of refugees and IDPs from HIV National Strategic Plans suggests that they may not be included in future national funding proposals to major donors.
:: Levels of viral suppression among refugees and nationals documented in a stable refugee camp suggest that some settings require more intensive support for all population groups.
:: Detailed recommendations are provided for refugees and IDPs accessing antiretroviral therapy in stable settings.